Your Thyroid Labs Are Normal, But You Still Feel Hypothyroid. Here's Why.

DIO2 is the enzyme responsible for converting T4 (the form your thyroid produces) into T3 (the active form your cells actually use). This happens in tissues throughout your body, not just in the thyroid. Without effective DIO2 function, you have all the T4 you need but your cells can’t activate it.

The DIO2 Ala/Ala variant, present in roughly 12-15% of the population, significantly impairs this conversion process. You can have a normal TSH and normal T4 on blood tests but still have tissue-level hypothyroidism because T3 production is reduced. This is why some people on standard levothyroxine never feel well; they have the substrate but not the enzyme efficiency to use it.

You’ll experience this as persistent fatigue despite treatment, brain fog that doesn’t lift, continued weight gain, and low body temperature (often 97-98 degrees). Your doctor might increase your dose, but if the problem is conversion, more T4 won’t help. You need T3.

Vitamin D doesn’t work through vitamin itself. It works through the VDR receptor on your cells. When vitamin D binds to VDR, it activates genes that regulate immune function, calcium absorption, and inflammation. In the thyroid context, VDR is critical for preventing autoimmune attack on your thyroid gland.

VDR variants (BsmI, FokI, TaqI) are carried by roughly 30-50% of the population, and they reduce your cells’ ability to absorb and activate vitamin D. You can take high-dose vitamin D supplements and still have functional vitamin D deficiency at the cellular level. Your blood test shows normal 25(OH)D levels, but your cells aren’t utilizing it effectively.

This compounds thyroid problems because low VDR function allows Th1 immune activation, which increases risk of Hashimoto’s thyroiditis and thyroid antibody production. You’ll feel this as worsening thyroid symptoms, especially if you have any autoimmune tendency, plus bone and muscle weakness despite supplementation.

MTHFR is the enzyme that converts dietary folate into the active methylated form (5-methyltetrahydrofolate) needed by your cells. More importantly, it drives the methylation cycle, which regulates thyroid antibody production and selenium-dependent enzyme function. Without adequate methylation, your immune system can’t regulate itself properly.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces enzyme efficiency by 40-70%. You can eat a diet rich in folate and still be functionally depleted in the methylated forms your thyroid enzymes require. This impairs both the enzymes that produce thyroid hormone and the immune regulation that prevents thyroid autoimmunity.

You’ll experience this as rising thyroid antibodies despite normal TSH, persistent autoimmune symptoms, brain fog that doesn’t improve with supplementation, and continued thyroid dysfunction even when medication is optimized. If you have Hashimoto’s, an MTHFR variant is one of the most common genetic factors driving your disease.

Iron is a cofactor in multiple thyroid enzymes, especially thyroid peroxidase (TPO), which synthesizes thyroid hormone. Without adequate iron, your thyroid can’t produce hormone efficiently. HFE regulates how much iron your intestines absorb and how your liver stores it. Variants in HFE alter this regulation.

The HFE H63D variant is carried by roughly 15-20% of people with European ancestry. While H63D doesn’t cause iron overload like the C282Y variant does, it often leads to functional iron dysregulation, leaving some people iron deficient despite adequate dietary intake. This is especially common in women and vegetarians.

You’ll feel this as persistent fatigue and cold intolerance even when thyroid hormone levels are optimized, difficulty with exercise recovery, brittle nails, and hair loss. If your ferritin is low or low-normal, an HFE variant is likely making it harder for you to absorb and retain iron, which then cascades into impaired thyroid enzyme function.

Vitamin D circulates in your blood attached to a binding protein called VDBP (vitamin D binding protein), encoded by the GC gene. This protein determines how much vitamin D stays stuck in transit versus how much is available to your cells. If your GC haplotype binds vitamin D too tightly, most of it stays unavailable.

GC haplotypes (1s, 1f, 2) are common, and certain combinations reduce the amount of free, bioavailable vitamin D even when your total 25(OH)D looks adequate. You can have a technically normal 25(OH)D blood test but still have a severe functional vitamin D deficiency because most of it is bound and unavailable to tissues. This is invisible on standard testing.

You’ll experience this alongside VDR variants as worsening autoimmune symptoms, bone and muscle weakness, and thyroid autoimmunity that doesn’t improve despite high-dose vitamin D supplementation. Your doctor sees normal blood work and assumes you’re supplementing enough, but your cells are starving.

BCMO1 is the enzyme that converts plant-based beta-carotene into retinol (active vitamin A). Vitamin A is essential for Th1 immune regulation and preventing autoimmune activation in the thyroid. Without adequate active vitamin A, your immune system can’t suppress thyroid-attacking T cells.

BCMO1 variants (R267S, A379V) are carried by roughly 45% of the population, and they reduce the efficiency of this conversion. You can eat abundant orange vegetables, spinach, and kale and still be functionally vitamin A deficient because your body isn’t converting the beta-carotene into the active form. This is especially true if you also have poor fat absorption or limited dietary fat to enable the conversion.

You’ll feel this as rising thyroid antibodies, worsening autoimmune symptoms, poor wound healing, and dry skin or vision changes. If you have Hashimoto’s and your antibodies are rising despite other interventions, inadequate active vitamin A is often the overlooked culprit.